Compare Wegovy and Mounjaro Through Expert Assessment
What Is Better Wegovy or Mounjaro for Online Prescriptions?
When deciding what is better Wegovy or Mounjaro through an online prescription service, the key advantage lies in having both options assessed by qualified prescribers without the traditional barriers of GP referrals or specialist appointments. EverydayMeds' clinical team evaluates your suitability for either medication based on your BMI, medical history, contraindications, and weight management goals during a comprehensive 3-minute assessment. This streamlined approach means you can explore both Wegovy (semaglutide) and Mounjaro (tirzepatide) options simultaneously, with expert guidance on which prescription-only medicine may be more suitable for your specific circumstances.
The online prescription process removes geographical limitations and appointment scheduling constraints that often delay traditional weight management consultations. Whether you're considering Wegovy's established GLP-1 mechanism or Mounjaro's dual GIP/GLP-1 approach, our licensed prescribers can provide evidence-based recommendations tailored to your clinical profile. Both medications require careful dose escalation and ongoing monitoring, making the accessibility of online prescribing particularly valuable for consistent treatment continuity.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding what is better Wegovy or Mounjaro from a cost perspective requires examining the complete pricing structure for each medication through online prescription services. At EverydayMeds, Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose—all prices include the FIRST40 discount code applied at checkout for new customers. Bundle options like the Intro Trio (0.25mg, 0.5mg, 1mg) cost £299.99, providing convenience through fewer orders and Reliable Supply continuity.
Mounjaro pricing follows a different structure due to its distinct dosing schedule and dual-agonist formulation, though both medications require similar clinical oversight and cold-chain storage during delivery. The prescription assessment fee, next-day delivery, and ongoing prescriber support are included in the stated prices for both medications. Returning customers benefit from the DOSE25 discount code, making long-term treatment more accessible through our GPhC-registered pharmacy service (#9012878).
Clinical Evidence: STEP Trials vs SURMOUNT Studies
When comparing what is better Wegovy or Mounjaro, the clinical evidence comes from different trial programmes with varying endpoints and participant populations. Wegovy's efficacy was demonstrated in the STEP clinical trial series, where patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight loss of around 15.2% at 2 years, while the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's evidence base stems from the SURMOUNT trial programme, evaluating tirzepatide's dual GIP/GLP-1 mechanism in weight management settings. Both medications have shown significant efficacy compared to placebo when used alongside reduced-calorie diet and increased physical activity, though direct head-to-head comparisons are limited due to different trial designs and participant characteristics.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone called glucagon-like peptide-1. This hormone is normally released by your intestines after eating and signals to your brain that you're full and satisfied. By activating GLP-1 receptors, Wegovy may help reduce appetite, promote feelings of fullness after smaller meals, and potentially reduce food cravings by working on the brain's appetite control centres. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety. Wegovy is administered as a once-weekly injection using Novo Nordisk's FlexTouch pen, with mandatory dose escalation from 0.25mg to the target maintenance dose of 2.4mg over 16 weeks.
Online Prescription Process: Assessment to Delivery
The process for obtaining either Wegovy or Mounjaro through EverydayMeds begins with a comprehensive 3-minute clinical assessment covering your medical history, current medications, BMI calculation, weight management goals, and screening for contraindications to either medication. Licensed UK prescribers review every submission within 3 working days (or 24 hours with express service), evaluating your suitability for either Wegovy or Mounjaro based on MHRA licensing criteria and NICE guidance. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using temperature-controlled cold-chain logistics. The assessment includes guidance on injection technique, dose escalation schedules, and integration with dietary and physical activity modifications. No GP referral is required, though we recommend informing your healthcare provider about any new weight management treatments.
Storage and Practical Considerations: Wegovy vs Mounjaro
When considering what is better Wegovy or Mounjaro for practical daily use, storage requirements present notable differences that may influence your choice. Wegovy offers superior travel flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use and utilise pre-filled injection pens for weekly self-administration. Wegovy's FlexTouch pen system from Novo Nordisk provides dose escalation through separate pen strengths, while Mounjaro uses Eli Lilly's dose-adjustable pen technology. The injection process is similar for both medications, typically administered subcutaneously in the abdomen, thigh, or upper arm, with injection site rotation recommended to prevent lipodystrophy.
Dual Agonist vs Single Agonist: Mechanism Comparison
The fundamental difference in what is better Wegovy or Mounjaro lies in their receptor targeting mechanisms, which may influence individual treatment responses and side effect profiles. Wegovy's semaglutide selectively activates GLP-1 receptors, providing targeted appetite suppression and satiety enhancement through a well-established pathway studied extensively in both diabetes and weight management contexts. Mounjaro's tirzepatide offers a dual agonist approach, simultaneously activating both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially providing enhanced metabolic benefits through multiple pathways.
This mechanistic difference may translate to varied individual responses, with some patients responding better to single-pathway GLP-1 activation, while others may benefit from the dual-receptor approach. Online prescription services like EverydayMeds enable patients to access expert clinical guidance on which mechanism might be more suitable based on their metabolic profile, diabetes status, and previous treatment responses. Both medications require ongoing monitoring and dose adjustments, making the accessibility of online prescriber support particularly valuable for optimising treatment outcomes.
Expert Prescriber Guidance: Making Your Choice
Determining what is better Wegovy or Mounjaro ultimately requires individualised clinical assessment rather than universal recommendations. Our experienced prescribers evaluate factors including your BMI, diabetes status, cardiovascular risk profile, previous weight management attempts, medication tolerances, and lifestyle considerations when recommending between these prescription-only medicines. The online consultation process includes detailed discussion of expected outcomes, potential side effects, dose escalation protocols, and long-term treatment planning for either medication option.
Both Wegovy and Mounjaro are available from EverydayMeds, ensuring you have access to whichever medication your prescriber determines most appropriate for your circumstances. New customers can begin their clinical assessment using discount code FIRST40, while returning patients benefit from DOSE25 pricing. Visit https://everydaymeds.co.uk/collections/wegovy to start your assessment or explore our comprehensive weight management support resources. Remember that successful weight management requires commitment to alongside dietary modifications and increased physical activity, regardless of which medication you choose.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
